- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 417/06 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 417/06
Total number of patents in this class: 1833
10-year publication summary
189
|
172
|
101
|
136
|
129
|
96
|
91
|
92
|
98
|
22
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2961 |
51 |
Janssen Pharmaceutica N.V. | 3839 |
43 |
Bristol-myers Squibb Company | 5080 |
38 |
Boehringer Ingelheim International GmbH | 4629 |
36 |
F. Hoffmann-La Roche AG | 7958 |
27 |
Achillion Pharmaceuticals, Inc. | 176 |
25 |
BASF SE | 19740 |
20 |
Merck Sharp & Dohme LLC | 3689 |
18 |
The Regents of the University of California | 18943 |
16 |
VALO Health, Inc. | 147 |
16 |
Biogen MA Inc. | 926 |
15 |
Shionogi & Co., Ltd. | 914 |
15 |
Astellas Pharma Inc. | 1145 |
13 |
Armagen, Inc. | 34 |
13 |
Abbott Laboratories | 2542 |
12 |
Vertex Pharmaceuticals Incorporated | 1581 |
12 |
Merck Patent GmbH | 5909 |
11 |
Syngenta Participations AG | 4970 |
11 |
Syngenta Crop Protection AG | 2790 |
11 |
Amgen Inc. | 3779 |
11 |
Other owners | 1419 |